<< Mitteilung

2019-06-24 17:50

Kiadis Pharma Announces Results Annual General Meeting

   

Kiadis Pharma Announces Results Annual General Meeting

Amsterdam, The Netherlands, June 24, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, announces that at its Annual General Meeting held today at 10:00 CEST at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands, all resolutions were duly passed by the shareholders.

For more information, please contact:

Kiadis Pharma:
Maryann Cimino, Manager, Corporate Affairs
Tel. +1 617 710 7305
m.cimino@kiadis.com
Optimum Strategic Communications:
Mary Clark, Supriya Mathur, Hollie Vile
Tel: +44 203 950 9144
David Brilleslijper (Amsterdam)
Tel: +31 610 942 514
kiadis@optimumcomms.com

About Kiadis Pharma
Founded in 1997, Kiadis Pharma, is a fully integrated biopharmaceutical company committed to developing innovative therapies for patients with late-stage blood cancers. With headquarters in Amsterdam, the Netherlands, and offices in the US and across Europe, Kiadis Pharma is leveraging the natural strengths of humanity and our collective immune system to source the best cells for life.

Kiadis Pharma is listed on the regulated market of Euronext Amsterdam and Euronext Brussels since July 2, 2015, under the symbol KDS. Learn more at www.kiadis.com.

Forward Looking Statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect Kiadis Pharma's or, as appropriate, Kiadis Pharma's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, Kiadis Pharma expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither Kiadis Pharma nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.




This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Kiadis Pharma N. V. via Globenewswire

Indizes

LU0916829079 572.6569 (-1.58%)

Aktien und Anleihen

Aktie Kurs Letz. +/-
Aperam (EUR) 20.34 20.88 -2.59%
ArcelorMittal (EUR) 12.208 12.488 -2.24%
BlueMarHoldings (EUR) 4.76 5.0 -4.80%
Brederode (EUR) 63.6 64.2 -0.93%
EDIFY act. ord. (EUR) 49.8 50.5 -1.39%
HellaGmbHKGaa (EUR) 36.22 37.48 -3.36%
ImmoLux-Airport (EUR) 270.0 272.0 -0.74%
Luxempart (EUR) 53.0 53.0 +0.00%
RTLGroup (EUR) 42.42 42.96 -1.26%
ReinetInvest (EUR) 14.0 14.7 -4.76%
SEO .prvB (EUR) 214.0 226.0 -5.31%
SEO 1/5prvB (EUR) 54.0 57.0 -5.26%
SES FDR (EUR) 14.215 14.23 -0.11%
SocFinCaoutchcs (EUR) 28.0 28.0 +0.00%
Socfinaf (EUR) 9.65 10.0 -3.50%
Socfinasia (EUR) 12.7 12.0 +5.83%
Vonovia (EUR) 43.23 43.06 +0.39%
Anleihe Kurs Letz. +/-
AXA 5,25% 16/04/2040 (EUR) 103.35 103.359 -0.01%
AirbusFinan 2,375% 02/04/2024 (EUR) 111.72 111.686 +0.03%
AlticeLux 7,25% 15/05/2022 (EUR) 102.595 102.52 +0.07%
Astaldi 7,125% 01/12/2020 (EUR) 26.0 25.5 +1.96%
BASF 2,5% 22/01/2024 (EUR) 111.841 111.839 +0.00%
BNGBank 4,375% 16/02/2021 (USD) 103.741 103.789 -0.05%
BNPParibas 4,875% pp (EUR) 102.31 102.674 -0.35%
BarclaysBank 4,75% pp (EUR) 97.031 96.991 +0.04%
Bayer 1,875% 25/01/2021 (EUR) 102.56 102.525 +0.03%
Bayer 2,375% 02/04/2075 (EUR) 101.96 101.698 +0.26%
Bekaert 5% 06/12/2019 (EUR) 101.331 101.346 -0.01%
BenOldmanESB 10% 23/10/2021 (EUR) 102.0 102.0 +0.00%
Bombardier 6,125% 15/05/2021 (EUR) 106.665 106.62 +0.04%
Bouygues 3,625% 16/01/2023 (EUR) 113.805 113.86 -0.05%
CasinoGuichardP FRN pp (EUR) 32.26 30.52 +5.70%
CmaCgm 7,75% 15/01/2021 Reg S (EUR) 92.605 92.633 -0.03%
Colombia 8,375% 15/02/2027 (USD) 120.75 119.75 +0.84%
CreditAgricole 7,875% pp (EUR) 101.496 101.476 +0.02%
Daimler 2% 25/06/2021 (EUR) 104.068 104.03 +0.04%
DeutscheBank 2% 02/12/2019 (USD) 96.78 96.75 +0.03%
DeutscheBank 2,2% 17/11/2020 (USD) 98.2 98.27 -0.07%
DtscheLufthansa 5,125% 12/08/2075 (EUR) 106.5 106.41 +0.08%
EFSF 1,875% 23/05/2023 (EUR) 109.54 109.46 +0.07%
EFSF 2,25% 05/09/2022 (EUR) 109.04 108.98 +0.06%
ENI 1,75% 18/01/2024 (EUR) 108.915 108.815 +0.09%
GazCapital 8,625% 28/04/2034 (USD) 139.071 138.827 +0.18%
GiePsaTresor 6% 19/09/2033 (EUR) 145.175 144.325 +0.59%
HeidelbergFinLu 7,5% 03/04/2020 (EUR) 104.78 104.64 +0.13%
HornbachBau 3,875% 15/02/2020 (EUR) 101.789 101.816 -0.03%
KfWA 2% 02/05/2025 (USD) 102.32 102.411 -0.09%
Lafarge 4,75% 23/03/2020 (EUR) 102.856 102.86 -0.00%
Luxembourg 2,125% 10/07/2023 (EUR) 111.68 111.565 +0.10%
Luxembourg 2,25% 19/03/2028 (EUR) 123.94 123.73 +0.17%
Luxembourg 2,25% 21/03/2022 (EUR) 108.07 107.98 +0.08%
Luxembourg 2,75% 20/08/2043 (EUR) 143.669 141.305 +1.67%
Luxembourg 3,375% 18/05/2020 (EUR) 102.94 102.955 -0.01%
MOBY 7,75% 15/02/2023 Reg S (EUR) 29.954 29.79 +0.55%
McDonalds 2% 01/06/2023 (EUR) 108.694 108.673 +0.02%
MerckFinServ 0,75% 02/09/2019 (EUR) 100.018 100.02 -0.00%
MüchenerRückGes 6% 26/05/2041 (EUR) 110.798 110.802 -0.00%
NBFinanceLtd FRN 07/02/2035 (EUR) 89.193 89.642 -0.50%
NordRheinWFalen 2,375% 16/09/2021 (USD) 101.28 101.346 -0.07%
NovoBanco 100 09/04/2052 (EUR) 19.482 19.42 +0.32%
NovoBanco 3,5% 02/01/2043 (EUR) 98.518 98.478 +0.04%
OMV 6,25% pp (EUR) 126.54 126.48 +0.05%
Pemex 6,5% 02/06/2041 (USD) 89.82 89.975 -0.17%
PetroVenezuela 12,75% 17/02/2022 (USD) 28.7 27.0 +6.30%
PetroVenezuela 5,375% 12/04/2027 (USD) 13.933 13.933 +0.00%
PetroVenezuela 5,5% 12/04/2037 (USD) 13.93 13.93 +0.00%
Philippines 4,2% 21/01/2024 (USD) 108.872 108.981 -0.10%
Portugal 5,125% 15/10/2024 (USD) 114.582 114.427 +0.14%
RWE 3,5% 21/04/2075 (EUR) 107.925 107.895 +0.03%
RWE 6,625% 30/07/2075 (USD) 111.39 111.435 -0.04%
RaiffeisenBkInt 6% 16/10/2023 (EUR) 120.401 120.402 -0.00%
RussianFed 7,5% 31/03/2030 (USD) 120.594 120.558 +0.03%
SNCFMobilites 4,875% 12/06/2023 (EUR) 120.966 120.944 +0.02%
Sanofi 1,75% 10/09/2026 (EUR) 112.902 112.83 +0.06%
StadaArzneimitt 1,75% 08/04/2022 (EUR) 102.353 102.906 -0.54%
SüdzuckIntlFin FRN pp (EUR) 73.978 73.957 +0.03%
TelecomItaliaCa 7,2% 18/07/2036 (USD) 109.772 109.705 +0.06%
TelecomItaliaFi 7,75% 24/01/2033 (EUR) 147.552 146.895 +0.45%
Thyssenkrupp 2,5% 25/02/2025 (EUR) 102.905 101.735 +1.15%
Turkey 7,375% 05/02/2025 (USD) 103.41 103.542 -0.13%
VWIntlFin 4,625% pp (EUR) 110.325 110.46 -0.12%
VWIntlFin 5,125% pp (EUR) 112.845 112.895 -0.04%
Venezuela 11,75% 21/10/2026 (USD) 17.457 19.685 -11.32%
VeoliaEnvironn 6,125% 25/11/2033 (EUR) 177.18 177.135 +0.03%
YPF 8,5% 28/07/2025 Reg S (USD) 78.873 78.54 +0.42%
ØRSTED A/S 6,25% 26/06/3013 (EUR) 120.195 119.82 +0.31%